BioStem Technologies, Inc. (BSEM) vs Celularity Inc. (CELU)
A side-by-side comparison of BioStem Technologies, Inc. and Celularity Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BSEM
BioStem Technologies, Inc.
$2.62HealthcareDelayed quote: Oct 6, 2026, 11:34 AM EDT
CELU
Celularity Inc.
$1.72HealthcareDelayed quote: Oct 6, 2026, 11:32 AM EDT
Total return — BSEM vs CELU
growth of $100 · dividends reinvested · last 7yBSEM +176.0% (+15.6%/yr)CELU -98.3% (-43.9%/yr)BSEM compounded faster over this window
Log scale — wide-divergence pair
BSEM CELU
BSEM vs CELU: by the numbers
- •CELU is the larger company ($50M vs $44M market cap).
- •Both run net losses; BSEM's is the smaller (-13.86% vs -375.77% net margin).
Metrics side by side
Valuation
| Metric | BSEM | CELU |
|---|---|---|
| P/S ratio | N/A | 2.62 |
| P/B ratio | 1.61 | N/A |
Profitability
| Metric | BSEM | CELU |
|---|---|---|
| Gross margin | 93.13% | 79.62% |
| Operating margin | -1.45% | -230.92% |
| Net margin | -13.86% | -375.77% |
| ROE | -102.45% | N/A |
| ROIC | -80.92% | -192.99% |
Growth (annualized)
| Metric | BSEM | CELU |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 8.31% |
| Total return CAGR (5Y) | 15.72% | -52.57% |
Frequently asked
- How have BSEM and CELU total returns compared?
- Over the past 5 years, BSEM delivered 15.72% and CELU delivered -52.57% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.